Streetbeat News

Price Targets

AKAM

Analysts have provided mixed ratings for Akamai Technologies (NASDAQ:AKAM) with 4 somewhat bullish, 2 indifferent, and 1 somewhat bearish ratings. The average 12-month price target for AKAM has been raised to $121.29, up from $107.00. Key analysts from firms like Keybanc, Susquehanna, and Morgan Stanley have adjusted their price targets and ratings, reflecting a response to market conditions and company performance. Akamai operates a significant CDN and security business, showing strong financial health with a market cap above industry average, a net margin of 16.63%, and an ROE of 3.73%. However, its revenue growth rate of 9.48% is below the IT sector average.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 3:00 pm

TEF

Telefonica Inc. (NYSE:TEF) stock is currently trading at $4.11, reflecting a 0.74% increase. Over the past month, TEF's stock has risen by 4.05%, and over the past year by 4.85%. The company's P/E ratio of 13.88 is significantly lower than the industry average of 53.5, suggesting it may be undervalued or expected to perform worse than its peers. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis for a comprehensive investment decision.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 3:00 pm

GLOB

Keybanc analyst Thomas Blakey has maintained an Overweight rating on Globant (NYSE:GLOB) and increased the price target from $218 to $266.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 2:59 pm

DBX

Keybanc analyst Thomas Blakey has maintained an Overweight rating on Dropbox (NASDAQ:DBX) and increased the price target from $32 to $37, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 2:57 pm

BAND

Keybanc analyst Thomas Blakey has maintained an Overweight rating on Bandwidth Inc. (NASDAQ:BAND) and increased the price target from $14 to $16.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 2:54 pm

AKAM

Keybanc analyst Brandon Nispel has maintained an Overweight rating on Akamai Technologies (NASDAQ:AKAM) and increased the price target from $134 to $138.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 2:51 pm

RARE

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) with a maintained price target of $114.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 2:33 pm

VFS

Cantor Fitzgerald analyst Andres Sheppard has reiterated an Overweight rating on VinFast Auto (NASDAQ:VFS) and maintained a $7 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 2:28 pm

AXGN

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Axogen (NASDAQ:AXGN) and maintained a $12 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 2:24 pm

SILK

Silk Road Medical's stock (SILK) is trading higher following an upgrade from Stifel, moving from a Hold to a Buy rating, with the price target also increased from $9 to $20.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 2:21 pm